research: selective reduction of inflammation to halt cancer growth

This research indicates that inflammation in breast tissue, spurred by the activity of the NFKB* pathway, causes cancer. If this inflammation can be isolated from the inflammation in the rest of the body and selectively treated, it could mean that breast cancer stem cells would die and halt the progression of the cancer.

*NFKB (nuclear factor kappa-light-chain-enhancer of activated B cells)

Breast Inflammation Is Key To Cancer Growth. In Medical News Today. 12/16/10

5 6 7 8
© 2004–2010 Donna Peach. All rights reserved.


Leave a Reply

Fill in your details below or click an icon to log in: Logo

You are commenting using your account. Log Out /  Change )

Google+ photo

You are commenting using your Google+ account. Log Out /  Change )

Twitter picture

You are commenting using your Twitter account. Log Out /  Change )

Facebook photo

You are commenting using your Facebook account. Log Out /  Change )


Connecting to %s